Middle east and Asia event
Free web source for technology events related to all sectors
Oracle Buys ClearTrial
 
 
Share on Facebook     Share on LinkedIn         WatsApp
 
Adds Leading Cloud-based Clinical Trial Operations and Analytics Applications to Oracle Health Sciences Suite

Dubai, United Arab Emirates - April 1, 2012

News Facts

· Oracle today announced that it has entered into an agreement to acquire ClearTrial, a leading provider of cloud-based Clinical Trial Operations (CTO) applications that make the planning, sourcing, and tracking of clinical projects and financial performance faster and more accurate.

· ClearTrial's activity-based costing solutions use embedded intelligence based on deep industry expertise to help life sciences companies manage the rising costs and increasing complexities of bringing new therapies to market.

· The combination integrates best-in-class functionality from ClearTrial with leading clinical trial execution and analytics capabilities from Oracle, creating the most comprehensive closed-loop clinical trial management offering from planning to payment.

· Biopharmaceutical and medical device companies are expected to significantly improve their ability to manage clinical trials across geographies, outsourcers, therapeutic areas and trial phases resulting in a better return on their R&D capital investments.

· Terms of the agreement were not disclosed. More information on this announcement can be found at http://www.oracle.com/cleartrial.

Supporting Quotes

· "Biopharmaceutical, medical device and diagnostic companies, as well as contract research organizations (CROs), are facing increasing pressure to deliver clinical development projects on time and within budget," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "Adding ClearTrial to the Oracle Health Sciences Cloud will help our customers streamline the clinical development process and help them bring therapies to market with greater predictability and at lower costs."

· "Clinical trials are being planned and managed with unprecedented rigor and specificity, given the industry's trend toward globalization of R&D and the continued growth in outsourcing," said Mike Soenen, chief executive officer, ClearTrial. "As the leading provider of technology and applications for the life sciences and healthcare industries, Oracle is the next logical step in our ability to best service our customers and extend our solution's reach."

-Ends-
Contact Info
Rachid El Hassani
CMG - Dubai
Mob. + 971 50 950 1525
Email: relhassani@cmgrp.com

Press release posted on: Apr 1 2012

Cloud company NetSuite helps UAE organizations scale and grow
Oracle Buys BlueKai
Crowd-sourcing project managed by Oracle Academy and Carnegie Mellon University makes “Alice” available to students in Arabic
Oracle Unveils Latest Technology Innovation in the State of Kuwait
Oracle Works with Infosys and Wipro to Extend Flexibility and Choice for Oracle Fusion Application Adoption for Oracle's PeopleSoft Customers
Qatar's Aspire Zone Foundation rolls out Oracle E-Business Suite R 12 to integrate sports business units
Oracle Unveils Oracle's AutoVue 20.2
Oracle Completes Acquisition of RightNow

CategoryDescription
Software Industry
 
http://www.oracle.com
Country: USA

Oracle (NASDAQ: ORCL.) is the worlds largest enterprise software company.

Mailing address:
Oracle Corporation
500 Oracle Parkway
Redwood Shores, CA 94065

General inquiries
+1.800.ORACLE1

International
+1.650.506.7000

Directions
Headquarters and Pleasanton
+1.650.506.0024













About us  |  Contact us  |  Partners  |  RSS
© 2024 MySolutionInfo.com